Global Cytokine Market Size study & Forecast, by Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-Il, Interferons-IFN, Epidermal Growth Factor-EGF, Other Cytokine Types), Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, an

Global Cytokine Market Size study & Forecast, by Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-Il, Interferons-IFN, Epidermal Growth Factor-EGF, Other Cytokine Types), Therapeutic Application (Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications), and Regional Analysis, 2022-2029

Global Cytokine Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2022-2029. Cytokines are cell signalling molecules that are released by various bodily cells. Cytokines are proteins that regulate a variety of physiological and metabolic processes and serve as a vital form of cell contact. The market is majorly driven by key factors such as the growing demand for cytokines for wound management and growing funding for cancer-based research.

According to Globocan 2020, 19,292,789 new cancer cases were registered. By 2040, this number is anticipated to reach 28,887,940. Additionally, in April 2022, at the American Association for Cancer Research (AACR) Annual Meeting 2022, Sonnet BioTherapeutics Holdings, Inc., a clinical-stage firm developing targeted immunotherapeutic medicines, presented data from preclinical research on the company's patented Fully Human Albumin Binding candidates, SON-1010, SON-1210, and SON-1410. However, high costs for Therapy stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cytokine Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the global market shares owing to the presence of competitors, mergers, acquisitions and research funding and the rising prevalence of cancer in the region. However, Asia Pacific is expected to be the fastest growing region owing to growing research and development funding from the government and an increasing number of pharmaceutical manufacturers.

Major market players included in this report are:
AstraZeneca plc
GlaxoSmithkline PLC
Johnson and Johnson
Pfizer Inc.
Novartis AG
Biocon Limited
Amgen Inc.
Sanofi SA
UCB S.A
AbbVie Inc.

Recent Developments in the Market:
 In July 2020, Derm-Biome Pharmaceutical and Pan-Biome Pharmaceutical stated that they had secured a pre-seed investment of US$ 500,000 to create drugs for the treatment of chronic inflammatory illnesses, including cytokines that reduce inflammation.
 A contract for the development and production of the medication Lenzilumab was signed in January 2021 by Emergent BioSolutions and Humanigen. This medication is intended to both prevent and treat an immunological hyper-reaction to the cytokine storm.

Global Cytokine Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Cytokines type, Therapeutics Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Cytokines Type:
Tumor Necrosis Factor-TNF
Interleukins-Il
Interferons-IFN
Epidermal Growth Factor-EGF
Other Cytokine Types
By Therapeutic Application:
Cancer
Asthma and Airway Inflammation
Arthritis
Other Therapeutic Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

AstraZeneca plc
GlaxoSmithkline PLC
Johnson and Johnson
Pfizer Inc.
Novartis AG
Biocon Limited
Amgen Inc.
Sanofi SA
UCB S.A
AbbVie Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.